News

The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

NanoString and Abcam Expand Collaboration to Advance Spatial Multiomics Research

Thursday, November 10, 2022

NanoString Technologies Inc a leading provider of life science tools for discovery and translational research and Abcam a global life science company working together

TILT Biotherapeutics Announces Boston Office Opening as it Expands its Clinical Trials in the US

Thursday, November 10, 2022

TILT Biotherapeutics a clinicalstage biotechnology company developing cancer immunotherapies announces that the company has opened an office in Boston to support its increasing US clinical development partnering and fundraising activities The current...

Salipro Biotech enters into collaboration and license agreement with Sanofi to advance discovery programs

Wednesday, November 09, 2022

Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration and license agreement with Sanofi on the discovery of therapeutic biologics against a challenging drug target The collaboration brings togeth...

Portage Biotech Announces Clinical Trial Collaboration Agreement with Merck

Wednesday, November 09, 2022

Portage Biotech Inc a clinicalstage immunooncology company developing therapies to improve patient lives and increase survival by avoiding and overcoming cancer

Aleta Biotherapeutics Receives Innovation Passport Designation for Biologic CAR T-Cell Therapy Engager ALETA-001

Tuesday, November 08, 2022

Aleta Biotherapeutics Aleta a privately held immunooncology company with novel biologic CAR T engagers that work in synergy with cell therapies to improve outcomes for patients

Nucleai Launches New Multiplex Imaging Spatial Analysis Solution to Increase Reliability and Speed of Immunofluorescence Analysis for Drug Discovery and Development

Tuesday, November 08, 2022

Nucleai a leader in AIpowered spatial biology today announced the expansion of its spatial biology platform to include a new generation of multiplex immunofluorescence mIF analysis that uses deep learning to establish new levels of accuracy speed and...

Shuttle Pharmaceuticals Engages Theradex Oncology in Preparation for Clinical Study

Friday, November 04, 2022

Shuttle Pharmaceuticals Holdings Inc a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy RT while reducing its side effects today announced it has enga...

Yuyu Pharma attendance at European Pharmaceutical Conference

Friday, November 04, 2022

Yuyu Pharmas CEO Robert Yu has been actively participating in biopharmaceutical conferences specifically BIOEurope in Leipzig and CPHI in Frankfurt held in Germany

QuantuMDx and Menarini Announce an Exclusive Distribution Agreement for the Q-POCâ„¢ Platform

Thursday, November 03, 2022

QuantuMDx Group Limited a UKbased developer of transformational PointofNeed molecular diagnostics and AMenarini Diagnostics SrI Menarini are pleased to announce an exclusive distribution agreement for QuantuMDxs QPOC platform in the UK and France

OrsoBio Announces Acquisition of LXR Inverse Agonist Program for Treatment of Severe Dyslipidemias from Phenex Pharmaceuticals

Thursday, November 03, 2022

OrsoBio Inc a clinicalstage biopharmaceutical company developing treatments for severe metabolic disorders today announced its acquisition of assets relating to the Liver X Receptor LXR inverse agonist program from Phenex Pharmaceuticals including le...